ArticleThe Journal of clinical investigation2018

Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies.

Sabrina Rizzolio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.